Soy Protein Supplementation Reduces Clinical Indices in Type 2 Diabetes and Metabolic Syndrome

PURPOSE: Clinical trials have studied the use of soy protein for treating type 2 diabetes (T2D) and metabolic syndrome (MS). The purpose of this study was to outline evidence on the effects of soy protein supplementation on clinical indices in T2D and MS subjects by performing a meta-analysis of ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi-Mei, Zhang, Yun-Bo, Chi, Mei-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800359/
https://www.ncbi.nlm.nih.gov/pubmed/26996569
http://dx.doi.org/10.3349/ymj.2016.57.3.681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800359/
https://www.ncbi.nlm.nih.gov/pubmed/26996569
http://dx.doi.org/10.3349/ymj.2016.57.3.681

Ejemplares similares